Published ahead of print on October 17, 2008, doi:10.1165/rcmb.2008-0037OC
© 2009 American Thoracic Society DOI: 10.1165/rcmb.2008-0037OC Salmeterol Restores Secretory Functions in Cystic Fibrosis Airway Submucosal Gland Serous Cells1 INSERM, UMRS 926, Reims, France; 2 Laboratoire de Microscopie Electronique Analytique, Université de Reims Champagne-Ardenne, Reims, France; 3 INSERM, UMRS 903, Reims, France; and 4 Laboratoire des Microscopies et Nanomatériaux, Université de Reims Champagne-Ardenne, Reims, France Correspondence and requests for reprints should be addressed to Franck Delavoie, Ph.D., INSERM UMRS 926, Laboratoire de Microscopie Electronique Analytique, 21 rue Clément Ader, B.P. 138, 51685 Reims Cedex 2, France. E-mail: franck.delavoie{at}univ-reims.fr The activity of the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) can be mediated by surface G protein–coupled receptors such as the β2-adrenergic receptor. In this study, we explored the effect of a long-acting β2-adrenergic agonist, salmeterol, on the CFTR-dependent secretory capacity of a human CF tracheal gland serous cell line (CF-KM4), homozygous for the delF508 mutation. We showed that, compared with the untreated CF serous cells, a 24-hour pre-incubation period with 200 nM salmeterol induced an 83% increase in delF508-CFTR–mediated chloride efflux. The restoration of the bioelectric properties is associated with increased apical surface pool of delF508-CFTR. Salmeterol induced a decrease in ion concentration and an increase in the level of hydration of the mucus packaged inside the CF secretory granules. The effects of salmeterol are not associated with a persistent production of cAMP. Western blotting on isolated secretory granules demonstrated immunoreactivity for CFTR and lysozyme. In parallel, we measured by atomic force microscopy an increased size of secretory granules isolated from CF serous cells compared with non-CF serous cells (MM39 cell line) and showed that salmeterol was able to restore a CF cell granule size similar to that of non-CF cells. To demonstrate that the salmeterol effect was a CFTR-dependent mechanism, we showed that the incubation of salmeterol-treated CF serous cells with CFTR-inh172 suppressed the restoration of normal secretory functions. The capacity of salmeterol to restore the secretory capacity of glandular serous cells suggests that it could also improve the airway mucociliary clearance in patients with CF.
Key Words: submucosal gland serous cell secretory granule salmeterol CFTR
Related articles in AJRCMB:
This article has been cited by other articles:
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||